## [Novartis in India](/in-en/about/novartis-india "Novartis in India") ## Novartis has had a significant footprint in India since 1947, with one legal entity namely, Novartis Healthcare Private Limited. India is amongst a handful of countries in the world that has a broad Novartis presence. This includes four divisions, namely: Pharma International (Commercial operations), Development (Drug development), Biomedical Research and Operations. ## Pharma International India Our commercial operations, Pharma International, are fully aligned to our global strategy of focusing on our innovative portfolios. To ensure that we are truly focused, we have narrowed down on our priority disease areas for India where we can create most value. We focus on core therapeutic areas with high unmet patient needs and utilize technology platforms that enable cutting-edge innovative therapies: Previous Next ![HCP in discussion with a happy senior citizen](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2024-01/hcp-discussing-with-smilling-senior-patient-card.jpg.jpg.webp?itok=Jl5rd4bd "HCP in discussion with a happy senior citizen") ### Cardiovascular, renal and metabolic Transforming how the world tackles cardiovascular disease and delivering new treatments for people with chronic kidney diseases. ![A HCP and patient discussing a report](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2024-01/doctor-patient-interacting-medical-results-card.jpg.jpg.webp?itok=7WEIlPkw "A HCP and patient discussing a report") ### Oncology (Solid Tumors and Hematology) Combining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones. ![A nurse and a patient enjoying a warm moment](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2024-01/nurse-patient-exchanging-warm-moment-card.jpg.jpg.webp?itok=szHIfvCk "A nurse and a patient enjoying a warm moment") ### Neuroscience, retina and transplant Committed to change the course of disease progression in neuroscience, retina and transplant. ![gene-blue-gradient-icon](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2024-01/gene-blue-gradient-icon.jpg.jpg.webp?itok=gjTTvaCJ "gene-blue-gradient-icon") ### Spinal Muscular Atrophy (Gene Therapy) Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body. ## Novartis Corporate Center India Novartis Corporate Centers (NOCCs) are key enablers of Novartis' priorities. We are positioned globally to bring together expert capabilities and talent across functions, to continuously support driving innovation and deliver excellence. The India site is the largest amongst the six centers we have globally and is supporting our purpose of reimagining medicine. This center houses: [ ![Scientists discussing at the lab](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2023-07/live-4.jpg.webp?itok=I4_HIhOo "live-4") ### Development Hub in India India serves as an important hub for Development, supporting various stages of development of medicines researched globally by Novartis. This center supports all the global development functions including Global Clinical Operations, Technical R&D, Patient Safety and Pharmacovigilance, Regulatory Affairs, Analytics and Clinical Development. ](/in-en/about/development) ![Scientist working in a lab](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2023-07/live-6.jpg.webp?itok=RMPSWtNm "Scientist working in a lab") ### Biomedical Research Globally, this division is a network of scientists, physicians, and business professionals using science and innovation to propel the discovery of high-value, next-generation medicines for patients. In India, we are committed to strengthening our existing capabilities to accelerate and support the global vision. ![Employees having a discussion at work](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2024-07/GettyImages-1434127313.jpg.webp?itok=BN88SIe7 "Employees having a discussion at work") ### Operations The capability center provides high-quality support service across multiple functions and capabilities to our sites across the world. These include Business Services, Data, Digital & IT, Manufacturing Supply, Quality, Procurement & Real Estate, Human Resources, Finance, Risk & Compliance, Legal, Communications amongst others. ## Creating Value in India ~9 mn #### Patients reached in India ~8,300 #### Total employees in India ### Returning to Society We are committed to championing sustainable livelihoods and empowering communities. Our focus areas are non-communicable diseases, eliminating leprosy and water neutrality. Through our initiatives in 2023, we have directly impacted: 150,000 #### Lives Effective 29 July 2026 Novartis India Limited (NIL) is no longer a part of Novartis AG and is now a part of the ChrysCapital group. To visit the Novartis India Limited website, click here: